nach oben

Erschienen in:

24.03.2022 | Original Article

Mid-Term Outcome of Left Ventricle Reverse Remodeling After Atrial Septal Defect Closure: A Comparison Between Surgical and Device Groups

verfasst von: Muflih Albalawi, Salim Ahmad, Mohamed Al Nasef, Abdulmajeed Alotay, Najlaa Al Rajaa, Atif Alsahari, Irfan Saleem, Jassim Mohamed Abudlhamed

Erschienen in: Pediatric Cardiology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

_Abstract

Right ventricular (RV) volume overload occurs in patients with significant atrial septal defect (ASD II) shunts, which can impair left ventricle (LV) filling, thus decreasing LV indices. However, after ASD II closure, the left ventricle regains near normal dimensions. The purpose of this study was to compare the long-term outcomes of LV reverse remodeling between device and surgical closure. We retrospectively reviewed the echocardiographic data of 222 patients with isolated ASD II who underwent surgical (95 patients) or device closure (127 patients) between January 2012 and December 2017. The ASD II was significantly larger in the surgical closure group (p < 0.001.) leading to a higher degree of paradoxical interventricular septal (IVS) movement. In contrast, the LV volume was larger in the device closure group (p < 0.001). After a median follow-up period of 19.5 months, the maximum LV systolic and diastolic volumes were reached at 1 year in the device closure group and 2 years in the surgical closure group. IVS motion normalized in 91% of the device closure group compared to 57% of the surgical closure group (p = < 0.001). There was significant improvement in left ventricular indices and IVS motion after ASD II closure in both groups but more favorable in patients after device closure.

Nur mit Berechtigung zugänglich

van der Linde D, Konings EEM, Slager MA et al (2011) Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 58(21):2241–2247CrossRef

Alabdulgader AA (2006) Congenital heart disease in Saudi Arabia: current epidemiology and future projections. East Mediterr Health J 12(Suppl 2):S157–S167 (PMID: 17361687)PubMed

Du Z-D, Cao Q-L, Koenig P, Heitschmidt M, Hijazi ZM (2001) Speed of normalization of right ventricular volume overload after transcatheter closure of atrial septal defect in children and adults. Am J Cardiol 88(12):1450–1453. https://doi.org/10.1016/S0002-9149(01)02135-XCrossRefPubMed

Louie EK, Lin SS, Reynertson SI, Brundage BH, Levitsky S, Rich S (1995) Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 92(4):819–824. https://doi.org/10.1161/01.CIR.92.4.819CrossRefPubMed

Butera G, Biondi-Zoccai G, Sangiorgi G et al (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7(3):377–385. https://doi.org/10.4244/EIJV7I3A63CrossRefPubMed

Berger F, Jin Z, Ishihashi K et al (1999) Comparison of acute effects on right ventricular haemodynamics of surgical versus interventional closure of atrial septal defects. Cardiol Young 9(5):484–487. https://doi.org/10.1017/S1047951100005394CrossRefPubMed

Foo JS, Lazu M, Pang SY, Lee PT, le Tan J (2018) Comparative analysis of right heart chamber remodeling after surgical and device secundum atrial septal defect closure in adults. J Interv Cardiol 31(5):672–678. https://doi.org/10.1111/joic.12528CrossRefPubMed

Pawelec-Wojtalik M, Wojtalik M, Mrowczynski W, Surmacz R, Quereshi SA (2006) Comparison of cardiac function in children after surgical and Amplatzer occluder closure of secundum atrial septal defects. Eur J Cardiothorac Surg 29(1):89–92. https://doi.org/10.1016/j.ejcts.2005.10.017CrossRefPubMed

Eerola A, Pihkala JI, Boldt T, Mattila IP, Poutanen T, Jokinen E (2007) Hemodynamic improvement is faster after percutaneous ASD closure than after surgery. Catheter Cardiovasc Interv 69(3):432–441. https://doi.org/10.1002/ccd.20962CrossRefPubMed

10.

Moore J, Hegde S, El-Said H et al (2013) Transcatheter Device Closure of Atrial Septal Defects. JACC Cardiovasc Intervent 6(5):433–442CrossRef

11.

Fraisse A, Latchman M, Sharma S-R et al (2018) Atrial septal defect closure: indications and contra-indications. J Thorac Dis 10(S24):S2874–S2881CrossRef

12.

Lopez L, Colan SD, Frommelt PC et al (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: A report from the pediatric measurements writing group of the American society of echocardiography pediatric and congenital heart disease council. J Am Soc Echocardiogr 23:465–95CrossRef

13.

Silvestry FE, Cohen MS, Armsby LB et al (2015) Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: From the American society of echocardiography and society for cardiac angiography and interventions. J Am Soc Echocardiogr 28(8):910–958. https://doi.org/10.1016/j.echo.2015.05.015CrossRefPubMed

14.

Du Z-D, Cao Q-L, Rhodes J, Heitschmidt M, Hijazi ZM (2002) Choice of device size and results of transcatheter closure of atrial septal defect using the Amplatzer septal occluder. J Intervent Cardiol 15(4):287–292CrossRef

15.

Tomar M, Khatri S, Radhakrishnan S, Shrivastava S (2011) Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol 4(1):22. https://doi.org/10.4103/0974-2069.79618CrossRefPubMedPubMedCentral

16.

Pascotto M, Santoro G, Cerrato F et al (2006) Time-course of cardiac remodeling following transcatheter closure of atrial septal defect. Int J Cardiol 112(3):348–352. https://doi.org/10.1016/j.ijcard.2005.10.008CrossRefPubMed

17.

Wu E-T, Akagi T, Taniguchi M et al (2007) Differences in right and left ventricular remodeling after transcatheter closure of atrial septal defect among adults. Catheter Cardiovasc Interv 69(6):866–871. https://doi.org/10.1002/ccd.21075CrossRefPubMed

18.

Tashiro H, Suda K, Iemura M, Teramachi Y (2017) Intergenerational differences in the effects of transcatheter closure of atrial septal defects on cardiac function. J Cardiol 70(6):620–626. https://doi.org/10.1016/j.jjcc.2017.03.014CrossRefPubMed

19.

Shaheen J, Alper L, Rosenmann D et al (2000) Effect of surgical repair of secundum-type atrial septal defect on right atrial, right ventricular, and left ventricular volumes in adults. Am J Cardiol 86(12):1395–1397. https://doi.org/10.1016/S0002-9149(00)01255-8CrossRefPubMed

20.

Vijayvergiya R, Singh J, Rana SS, Shetty R, Mittal BR (2014) Early and six-month assessment of bi-ventricular functions following surgical closure of atrial septal defect. Indian Heart J 66(6):617–621. https://doi.org/10.1016/j.ihj.2014.10.411CrossRefPubMedPubMedCentral

21.

Rhee EK, Evangelista JK, Nigrin DJ, Erickson LC (2000) Impact of anatomic closure on somatic growth among small, asymptomatic children with secundum atrial septal defect. Am J Cardiol 85(12):1472–1475. https://doi.org/10.1016/S0002-9149(00)00797-9CrossRefPubMed

22.

Teo KS, Dundon BK, Molaee P et al (2008) Percutaneous closure of atrial septal defects leads to normalisation of atrial and ventricular volumes. J Cardiovasc Magn Reson 10(1):55. https://doi.org/10.1186/1532-429X-10-55CrossRefPubMedPubMedCentral

23.

Salehian O, Horlick E, Schwerzmann M et al (2005) Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol 45(4):499–504. https://doi.org/10.1016/j.jacc.2004.10.052CrossRefPubMed

24.

Maatouk F, Farhat B, Betbout F, Gamra H, Ben Hamda K, Jarrar M, Hammami S, Added F, Ben Gadha N, Dridi Z (2001) Right ventricular dilatation and intraventricular septal motion after surgical closure of atrial septal defect. Arch Mal Coeur Vaiss 94(3):204–10PubMed

25.

Clancy DJ, Mclean A, Slama M, Orde SR (2018) Paradoxical septal motion: A diagnostic approach and clinical relevance. Australas J Ultrasound Med 21(2):79–86. https://doi.org/10.1002/ajum.12086CrossRefPubMedPubMedCentral

26.

Reynolds HR, Tunick PA, Grossi EA, Dilmanian H, Colvin SB, Kronzon I (2007) Paradoxical septal motion after cardiac surgery: A review of 3,292 cases. Clin Cardiol 30(12):621–623. https://doi.org/10.1002/clc.20201CrossRefPubMedPubMedCentral

27.

Kuijpers JM, Mulder BJM, Bouma BJ (2015) Secundum atrial septal defect in adults a practical review and recent developments. Neth Heart J 23(4):205–211CrossRef

Titel: Mid-Term Outcome of Left Ventricle Reverse Remodeling After Atrial Septal Defect Closure: A Comparison Between Surgical and Device Groups
verfasst von: Muflih Albalawi
Salim Ahmad
Mohamed Al Nasef
Abdulmajeed Alotay
Najlaa Al Rajaa
Atif Alsahari
Irfan Saleem
Jassim Mohamed Abudlhamed
Publikationsdatum: 24.03.2022
Verlag: Springer US
Erschienen in: Pediatric Cardiology / Ausgabe 7/2022
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-022-02879-z

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Correction to: A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation

Primary Disease, Sex, and Racial Differences in Health-Related Quality of Life in Adolescents and Young Adults with Heart Failure

Transcatheter Versus Surgical Closure of Acute Ruptured Sinus of Valsalva Aneurysms with Associated Ventricular Septal Defects

Improved Exercise Tolerance in an Adolescent Female After Failed Fontan and Subsequent Biventricular Conversion

Late Outcomes of Transcatheter Coarctation Intervention in Infants with Biventricular Anatomy

Post-operative Anticoagulation Strategy Following Comprehensive Stage 2 Procedure for Single Ventricle Physiology